Interestingly, this resistance was labile and reversible after hypoxic reversion or HIF-1α inhibition, highlighting the potential relevance to counteract hypoxia in ALK-rearranged tumours harbouring TKI resistances. The gene discussed is ALK; the disease is neoplasm.